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Chemotaxise immune response, and HIV-infected individuals demonstrate altered NK cell
phenotype and function. We ﬁnd that CD4+ NK cells are susceptible to HIV infection; this could account for
the NK cell dysfunction seen in HIV-infected individuals. CD4+ NK cells express CXCR4 and can be infected
with X4-tropic viruses and some primary R5-utilizing viral isolates. Treatment with the CXCR4 ligands
AMD3100 and SDF-1α partially blocks infection with X4-tropic virus, treatment with anti-CCL Igs
upregulates CCR5 surface expression and enables infection with HIV-Bal. HIV infection of NK cells results
in CD4 downregulation and the production of infectious virus. HIV-infected CD4+ NK cells mediate NK cell
cytotoxicity, however, HIV infection is associated with decreased chemotaxis towards IL-16. Thus, HIV
infection of CD4+ NK cells could account for the NK cell dysfunction observed in HIV-infected individuals.
Furthermore infected NK cells could serve as a viral reservoir of HIV in vivo.
© 2009 Elsevier Inc. All rights reserved.Introduction
HIV infection is characterized by the loss of CD4+ T lymphocytes
and global immune dysfunction. Although declining CD4+ T cell
number and function is the hallmark of HIV pathogenesis, the
consequences of HIV infection also extend to the innate immune
system. Loss of Natural Killer (NK) cell activity has been correlated
with HIV disease progression (Ahmad and Menezes, 1995; Brenner et
al., 1994; Ratcliffe et al., 1994), and there is an inverse correlation
between viremia and NK cell-mediated CCL-chemokine production
(Kottilil et al., 2003). NK cell receptor expression is also altered in the
setting of HIV infection (Ahmad et al., 2001), and new evidence
indicates that DC/NK cell interactions are inﬂuenced by HIV infection
(Mavilio et al., 2006). As NK cells play a key role in the innate immune
response against malignancy and infection, altered NK cell function
could impact HIV disease progression, tumorigenesis, and the
acquisition of opportunistic infections.edical Center, Department of
dicine, 11100 Euclid Avenue,
H 44106216-368-0744, USA.
spitals.org (H.B. Bernstein).
ll rights reserved.We previously identiﬁed CD4+ NK cells in vivo and have studied
the function of CD4+ NK cells in vitro (Bernstein et al., 2006). CD4+
NK cells mediate cytotoxicity against susceptible target cells and CD4
expression is associated with increased production of the cytokines γ-
IFN and TNF-α. CD4+ NK cells are capable of migrating towards the
proinﬂammatory cytokine IL-16, which is a CD4 ligand. Furthermore,
CD4 ligation increases cytokine production by NK cells. Thus CD4 has a
role in NK cell function, increasing cytokine production and directing
cell migration. However, susceptibility to HIV infection is a potential
consequence of CD4 expression and HIV infection of NK cells could
account for the altered NK cell function observed in HIV-infected
individuals.
In the current studywe ﬁnd that CD4+NK cells robustly express the
HIV co-receptor CXCR4 and haveminimal CCR5 expression. Low surface
expression of CCR5 is likely secondary to CCL chemokine production
and can be enhanced by treating cells with an excess of anti-CCL
antibodies. As other CD4 expressing cells, including macrophages, CD8
+ T cells, and NKT cells have been found to be susceptible to HIV
infection (Fleuridor et al., 2003; Kitchen et al., 1998; Lusso et al., 1991;
Motsinger et al., 2002), we challenged our CD4+NK cells withmultiple
strains of HIV, including primary virus isolates.We found that CD4+NK
cells are susceptible to infection with HIV and produce infectious virus.
HIV infection is accompanied by CD4 downregulation and diminished
migration towards the cytokine IL-16; however cytotoxicity is
Fig. 1. HIV co-receptor expression on stimulated NK cells. Puriﬁed NK cells were stimulated for 14 days with IL-2, IL-12 and PHA and stained with ﬂuorochrome-labeled monoclonal
Abs to CD56, CD4, and either CXCR4 or CCR5. Flow cytometry was performed on these samples, gating included live cells expressing CD56. We found that 86% of our gated cells
expressed CXCR4 (black population) in our histogram analysis (isotype in gray). CCR5 expression was minimal (black population), at less than 3% compared to our isotype control
(gray population). Results are representative of at least 5 independent experiments.
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for HIV infection, which results in altered NK cell function. This could
account for the NK cell dysfunction observed in HIV-infected patients.
Results
CD4+ NK cells express HIV co-receptor
CXCR4 and CCR5 surface expression on CD4+NK cells was assessed
by ﬂow cytometric analysis. We observed robust CXCR4 expression and
minimal CCR5 expression on CD4+ NK cells obtained following
stimulation with IL-2, IL-12 and PHA (Fig. 1). Approximately 50% of
the cells expressed CD4 in the shown assay and there were no CD3+Fig. 2.HIV infection of stimulated NK cells. Puriﬁed, stimulated NK cells were either mock inf
cells were permeabilized and stained with ﬂuorochrome-labeled mAbs in the following com
exclude dead cells. The dot plots represent cells gated based on size and 7AAD exclusion. The
plot to the immediate left, with arrow). Results are representative of at least 5 independencells in our culture conditions. Cells were also negative for other lineage
speciﬁc markers including: CD19, CD14, TCR α/β and γ/δ, and
TCRVα24, Vβ11. To further evaluate CCR5 expression, we phenotyped
PBMC-derived NK cells immediately ex vivo. Some of these cells did
express CCR5 on their surface, however, CD4 expressionwasminimal at
this time (data not shown). Our ﬁnding of absent CCR5 surface
expression on activated NK cells is consistent with studies by
Inngjerdingen et al. (2001), who observed an absence of CCR5
expression on activated or nonactivated NK cells, although other
investigators have observed CCR5 expression on activated NK cells
(Nieto et al., 1998; Valentin et al., 2002).
CD4+ NK cells are potent producers of the CCL chemokines CCL3
(MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES), which could serve toected (top) or challenged with either HIV-IIIB or HIV-Bal. Post-infection day 7 aliquots of
bination: CD56-PE, KC57-FITC (p24 gag), CD4-APC, and 7AAD staining was performed to
plot at the far right represents a gated subset of p24 expressing cells (gate shown on dot
t experiments.
Fig. 3. HIV infection of stimulated NK cells. Puriﬁed, stimulated NK cells were either mock infected) or infected with HIV. Post-infection day 5 aliquots of cells were stained with
ﬂuorochrome-labeled mAbs in the following combination: CD56-PE, KC57-FITC (p24 gag), CD3-PerCP, and CD4-APC. The histograms demonstrate KC57 (p24 gag) staining cells are
gated based on size and CD56 staining, all cells were CD3 negative. HIV-IIIB, BZ167, QZ4589 and 96USHIPS9 challenged cells reveal bimodality, signifying a KC57 positive
subpopulation, whereas mock infected and HIV-Bal histograms are unimodal.
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and internalization. To determine whether our inability to detect
signiﬁcant CCR5 expression on the cell surface correlates with CCR5
gene expression, we quantitated CCR5 mRNA by reverse transcription
followed by real time PCR. We found that CD4+ NK cells do express
CCR5 mRNA. CD4+ NK cells had approximately 10 fold less CCR5
mRNA (normalized to GAPDH mRNA) than peripheral blood mono-
nuclear cells from the same donor (data not shown). These ﬁndings
indicate that CCR5 expression is downregulated post-transcriptionally
and suggests that activated NK cells produce sufﬁcient quantities of
CCL-chemokines to downregulate CCR5 surface expression.
CD4+ NK cells can be infected with HIV
Following conﬁrmation of co-receptor expression, CD4+ NK cells
were infected with either HIV-IIIB or -Bal at a MOI of 0.1 in theFig. 4. Treatment with anti-CCL antibodies results in enhanced CCR5 expression and permit
anti-CCL Igs for 3 days followed by challenge with HIV-Bal. At four days post-infection c
histograms demonstrate KC57 (p24 gag) and CCR5 staining, anti-CCL Ig treated cells are w
infected and HIV-Bal challenged NK cells (in the presence or absence of anti-CCL Igs), the ppresence of polybrene. Following viral incubation, cells were washed
3× to remove unbound virus and cultured in media with cytokines as
described (Bernstein et al., 2006). At ﬁve days post-infection, surface
antibody staining with CD56-PE, CD3-PerCP, and CD4-APC and
intracellular antibody staining with KC57-FITC followed by ﬂow
cytometric analysis was performed (Kitchen et al., 2004). Following
challenge with X4 tropic HIV-IIIB approximately 14% of cells were
positive for intracellular p24 antigen (Fig. 2). Infection of CD4+ NK
cells from other donors resulted in up to 24% of CD56+ cells
expressing p24 antigen, all KC57+ cells were CD56+ and no CD3+
cells were detected in our assay. We observed diminished CD4
expression in NK cell cultures infected with HIV. Downregulation of
CD4 is a well described phenomenon within HIV-infected CD4+ T
cells (Chen et al., 1996), thus our ﬁndings demonstrate similar
phenotypic changes following HIV infection of NK cells. As CD4
expression was diminished in both KC57+ and KC57− cells, ours infection with HIV-Bal. Puriﬁed NK cells were cultured in the presence of an excess of
ells were stained with CCR5-PE, KC57-FITC (p24 gag), CD56-ECD, and CD4-APC. The
hite and untreated cells are black. Dot plots show CD4 and KC 57 expression in mock
ercent of KC57 cells is shown in the top right of each dot plot.
Fig. 5. HIV-IIIB Infection of CD4+ NK cells is mediated by the CXCR4 coreceptor. Puriﬁed NK cells were cultured in the presence of AMD3100 or SDF-1α followed by challenge with
HIV-IIIB. At four days post-infection cells were stained with CD56-PE, KC57-FITC (p24 gag), and CD4-APC. Dot plots show CD4 and KC 57 expression in mock infected and HIV-IIIB
challenged NK cells some of which were treated with AMD3100 or SDF-1α. The percent of KC57 cells is shown in the top right of each dot plot.
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infected cells versus HIV-mediated cell killing.
Following mock infection or challenge with R5 tropic HIV-Bal,
there was no intracellular p24 detected (by KC57 staining) and CD4
expression remained constant (Fig. 2). These ﬁndings correlate with
our co-receptor expression, as shown in Fig. 1. Other investigators
have reported NK cell infection with HIV-JR-CSF (Valentin et al.,
2002); however, there was signiﬁcant CCR5 expression on the NK
cells challenged with HIV-JR-CSF. These phenotypic changes could
be secondary to different culture conditions, as our cells were
grown in the presence of PHA, IL-12 and IL-2 to induce CD4
expression. Moreover, this phenotypic difference could account for
the differing results. A recent paper describes infection of CD4+ NK
cells with the R5-utilizing, primary isolate HIV-JR-FL; however, co-
culture with HIV-infected T cells was required for infection as theyFig. 6. Kinetics of HIV replication in CD4+ NK cells. Puriﬁed, stimulated NK cells were infect
analysis and cell culture supernatants were removed and assayed for the presence of p24 at
some conditions were cultured in the presence of AZT following a 2 hour viral attachmentwere unable to directly infect CD4+ NK cells with cell free virus
(Harada et al., 2007).
Given that others have successfully infected CD4+ NK cells with
R5-utilizing viruses, we challenged our CD4+ NK cells with primary
HIV isolates HIV-1 QZ4589 (clade B, R5), HIV-1 BZ167 (clade B, X4),
and HIV-1 96USHIPS9 (clade B, R5/X4) obtained from the AIDS
Research and Reference Reagent Program, Division of AIDS, NIAID, NIH
from Drs. F. Cleghorn, C. Bartholomew, N. Jack, M. Greenberg, W.
Blattner, and K. Weinhold (HIV-1 QZ4589), J. Mascola (HIV-1 BZ167),
D. Ellenberger, P. Sullivan, and R. B. Lai (HIV-1 96USHIPS9) (Cecilia et
al., 1998; Ellenberger et al., 1999; Louwagie et al., 1994; Sullivan et al.,
1999; Zolla-Pazner and Sharpe, 1995). Each of these primary isolates
was able to infect CD4+ NK cells, with infection conﬁrmed by
intracellular p24 antibody staining (Fig. 3). Cells from the same donor
were also challenged with HIV-IIIB and HIV-Bal. As observed in Fig. 2,ed with HIV-IIIB at an MOI of 0.1. KC 57 expression was quantitated via ﬂow cytometric
the indicated days post infection. Data shown is representative of a duplicate infection,
period. Results are representative of 3 experiments.
Table 1
Quantitation of infectious virus production by HIV-infected NK cells
Day 7a Day 10a
No AZT 80 infectious units/ml 5120 infectious units/ml
AZT 20 infectious units/ml 20 infectious units/ml
a Cell culture supernatant from HIV-infected NK cells, cultured in the presence or
absence of AZT, was added to PHA stimulated blasts in serial 4 fold dilutions on the day
post-infection indicated. HIV-infection of blasts was determined by p24 release into
supernatant, calculation of infectious HIV particles/ml was performed using standard
methods.
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was seen in HIV-Bal challenged cells. Thus, CD4+ NK cells are
susceptible to infectionwith primary viral isolates of HIV, including R5
utilizing viruses. These ﬁndings indicate that CD4+ NK cells could
play an important role in HIV pathogenesis in vivo.
HIV infection of NK cells is dependent on co-receptor expression
Our inability to successfully infect CD4+ NK cells with HIV-Bal
could be secondary to HIV-Bal requiring higher levels of CCR5
expression for entry than other R5-utilizing strains of HIV. To
investigate this possibility, CD4+ NK cells were treated with an
excess of anti-CCL antibodies for 3 days. We observed upregulation of
CCR5 surface expression following incubation (data not shown).
These cells were then challenged with HIV-Bal. At 4 days post
infection cells treated with anti-CCL antibodies had enhanced CCR5
surface expression and evidence of HIV infection as assessed by p24
(KC 57) expression (Fig. 4). Intracellular KC57 staining was used to
demonstrate infection, limiting the possibility of virus carryover
causing falsely positive results. CD4+ NK cells from the same donor
that were mock infected or not treated with anti-CCL antibodies had
less CCR5 expression and were negative for intracellular p24
expression.Fig. 7. HIV-infected NK cells mediate NK cell cytotoxicity. CD4 expressing NK cells were in
incubated with 51Cr-labeled K562, 2F7, Ramos, or Daudi cells for 4 h using effector: target rat
was quantitated to measure NK cell cytotoxicity. Total release (targets lysed with 0.5% triton
and % cytotoxicity was calculated by comparing samples to the total release (100%) and spon
shown. HIV-infected NK cells had diminished cytotoxic activity against Daudi cells at E:T rati
same donor. These data are representative of three independent experiments performed wTo assess the role of CXCR4 in mediating HIV infection of NK cells,
CD4+ NK cells were treated with either AMD3100 or SDF-1α prior to
challenge with HIV-IIIB. Culture with either AMD3100 or SDF-1α
diminished KC57 expression substantially (Fig. 5), suggesting that
CXCR4 plays an important role in virus entry of NK cells. Together
these studies support the concept that HIV infection of CD4+ NK cells
occurs via the coreceptors CXCR4 and CCR5.
HIV-infected NK cells produce infectious HIV
To determinewhether CD4+NK cells are productive hosts for viral
infection, we assessed kinetics of virus release following infection. We
found signiﬁcant release of p24 antigen into cell culture supernatants
over time following infection, as detected by ELISA (Fig. 6) (Brooks
and Zack, 2002), suggesting that NK cells can serve as productive hosts
for HIV infection. Additionally, treatment with AZT substantially
diminished intracellular p24 expression, compared to untreated cells
from the same donor (Fig. 6). We then performed a limiting dilution,
viral quantitative culture (Chun et al., 1997) on supernatant fromHIV-
infected NK cells to determine whether released p24 antigen was
associated with infectious virus. Duplicate cultures were performed
and HIV-infected NK cells were cultured in either the absence or
presence of AZT. We found that HIV-infected NK cells produced
increasing quantities of infectious HIV over time, our limiting dilution
culture quantitated 5120 infectious units of HIV/ml on day 10 post-
infection. Furthermore, AZT treatment of HIV-infected NK cells
virtually eliminated release of infectious virus (Table 1).
The impact of HIV infection on NK cell cytotoxicity
Our prior work demonstrated that CD4+ NK cells are potent
mediators of NK cell cytotoxicity (Bernstein et al., 2006). Given that
others have found diminished NK cell killing in HIV-infected
individuals (Ahmad and Menezes, 1995; Brenner et al., 1994; Ratcliffefected with HIV-IIIB (or mock infected) and at 5 days post-infection viable cells were
ios ranging from 0.625–10:1. 51Cr release from target cells into cell culture supernatants
) and spontaneous release (no effector cells) controls were performed with each assay
taneous release (0%) controls. Each condition was assayed in triplicate and averages are
os 2.5 and below, ⁎P=0.01, +P=0.05, when compared to uninfected samples from the
ith separate donors.
Fig. 8. HIV infection decreases CD4+ NK cell migration towards IL-16. HIV-IIIB infected or mock infected CD4+ NK cells (day 5 post-infection) at a concentration of 1×106 cells/ml
were placed in the upper chamber of a Costar transwell plate and allowed to migrate for 4 h in response to 200 ng/ml IL-16 or 20 ng/ml SDF-1α. Results are the percentage of cells
migrating compared with the medium only controls (spontaneous migration, set at 100%). Cell migration was quantiﬁed by counting cells in the lower chamber of the chemotaxis
chamber at the conclusion of the migration period. Triplicate wells were performed for each condition, and averages were calculated. Data shown is representative of the results
obtained following three independent experiments using NK cells derived from different donors. HIV-infection of NK cells was associated with a statistically signiﬁcant decrease in
migration towards the cytokine IL-16 (P=0.05).
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impairs NK cell cytotoxicity. NK cell killing by HIV-infected and
uninfected cells from the same donor was assessed using a standard
cytotoxicity assay quantitating chromium release from radiolabeled
target cells. We found that HIV-infected NK cells retained the ability to
mediate killing of several target cell lines, including K562, Ramos,
Daudi, and 2F7 cells (Fig. 7). Although there appeared to be modest
decreases in NK cell cytotoxicity mediated by the HIV-infected NK
cells, cytotoxic activity against Daudi cells at lower effector to target
cell ratios (2.5 (P=0.01), 1.25 (P=0.01), 0.625 (P=0.01), 0.3125
(P=0.05)) were the only conditions that reached statistical signiﬁ-
cance using a two-sided Wilcoxon Rank Sum test with appropriate
corrections for multiple analysis.
HIV infection decreases CD4+ NK cell migration towards IL-16
CD4+ NK cells migrate towards the proinﬂammatory cytokine IL-
16 (Bernstein et al., 2006), which is a ligand for CD4. In vivo, this
function could direct CD4+NK cells to sites of inﬂammation and virus
production. We tested the ability of HIV-infected NK cells (day 5 post-
infection) to migrate towards the cytokine IL-16 in migration assays
performed as previously described (Bernstein et al., 2006). SDF-1α
was used as a positive control, there was no difference in migration
towards this chemoattractant comparing HIV-infected and uninfected
cells (P=NS). We found that HIV infection caused a statistically
signiﬁcant reduction in NK cell migration towards IL-16 (Fig. 8), as
assessed by the Wilcoxon Rank Sum test, a nonparametric test that is
powerful in small sample sizes. This ﬁnding is likely secondary to
downregulation of CD4 on NK cells following HIV infection. This
functional consequence of HIV infection could alter the NK cell's
ability to localize to sites of inﬂammation and mediate cytokine
production and/or cytotoxicity within these tissues in vivo.
Discussion
Our previous study identiﬁed CD4+ NK cells in vivo and studied
the function of these cells (Bernstein et al., 2006). CD4+ NK cells
mediate cytotoxicity against susceptible target cells and are capable of
migrating towards the proinﬂammatory cytokine IL-16, which is a CD4ligand. CD4 expression is associated with increased production of the
cytokines γ-IFN and TNF-α. Additionally, CD4 ligation increases
cytokine production by NK cells. Thus CD4 has a role in NK cell
function, increasing cytokine production and directing cell migration.
However, susceptibility to HIV infection is a potential consequence of
CD4 expression and direct infection of NK cells could account for the
altered NK cell function observed during HIV infection.
In this study, we demonstrate that CD4+ NK cells robustly express
the HIV co-receptor CXCR4 and have minimal CCR5 expression. Other
published reports demonstrated both a lack (Inngjerdingen et al.,
2001) and presence of CCR5 expression on activated NK cells (Nieto et
al., 1998; Valentin et al., 2002). We also found that CD4+ NK cells are
susceptible to infection with the X4 tropic HIV-IIIB and primary virus
isolates utilizing X4 and/or R5; however, they are resistant to infection
with the R5-tropic HIV-Bal. Treatment of CD4+NK cellswith an excess
of anti-CCL Igs upregulates CCR5 expression, permitting infectionwith
HIV-Bal. Thus it appears likely that the resistance of untreated CD4+
NK cells to infection with HIV-Bal is secondary to insufﬁcient co-
receptor expression caused by CCL chemokine production. These
ﬁndings correlate with work by Valentin et al. (2002) and another
recently published study describing infection of CD4+ NK cells with
the R5-utilizing, primary isolate HIV-JR-FL (Harada et al., 2007). HIV-
infected NK cells produce infectious virus, conﬁrming that they can
serve as a cellular host toHIV, and raising thepossibility that theycould
serve as a viral reservoir. Support for the notion that HIV-infected NK
cells are present in HIV-infected individuals and that NK cells might
serve as a viral reservoir in vivo is provided by work of Valentin et al.
(2002), who cultured infectious virus and PCR ampliﬁed proviral HIV
DNA from NK cells obtained from HIV-infected individuals.
HIV infection of NK cells results in downregulation of CD4
expression, this is a newly reported ﬁnding. CD4 downregulation is
a well described phenomenon within HIV-infected CD4+ T cells
(Chen et al., 1996), thus our ﬁndings reveal similar phenotypic
changes following HIV infection of NK cells. Furthermore, CD4
downregulation on HIV-infected NK cells has functional conse-
quences, as we observed diminished migration towards the cytokine
IL-16 in HIV infected NK cells.
The impact of HIV infection on NK cell cytotoxic activity was
modest, signiﬁcantly diminished NK cell killing was observed only
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below). We assessed the ability of HIV-infected NK cells to kill
standard, well characterized target cell lines as these cells have been
extensively used to assess NK cell cytotoxicity and results can be
compared between individuals. Limitations are that these cells do not
represent infected primary CD4+ T cells and that the four hour
incubation period utilized does not enable assessment of “potential”
long term consequences of HIV infection on NK cells such as viral-
induced NK cell death. Further, subtle changes in cytotoxic activity
could bemasked by the presence of normal HIV-uninfected NK cells as
approximately 20% of the cells used in this assay expressed p24. HIV
infection of NK cells was initially described in 1988 and was
accompanied by a loss of NK cell lytic activity (Robinson et al.,
1988). However, this early study assessed lytic activity of a PBMC
culture infected with HIV. Infectionmay have impacted the number of
NK cells in the culture and/or altered other cells that could interact
with NK cells modulating NK cell function. We utilized a puriﬁed NK
cell population in our assay, and quantitated NK cell input enabling
direct comparison of HIV-infected and uninfected cells, enhancing the
validity of our results.
We have demonstrated that NK cells express the receptors
necessary for HIV infection, CD4 and CXCR4, and can be productively
infected with HIV, resulting in altered function of HIV-infected cells.
Although we were not able to detect signiﬁcant CCR5 expression on
the surface of CD4+ NK cells, we were able to demonstrate the
presence of CCR5 mRNA within CD4+ NK cells and these cells were
susceptible to infection with primary HIV isolates utilizing the CCR5
co-receptor. Thus NK cells could serve as cellular hosts in vivo for HIV,
and could potentially function as a reservoir, as suggested by other
investigators (Valentin et al., 2002). Further study is required to better
delineate the consequences of HIV infection on other functions of NK
cells and to assess the frequency and function of HIV-infected NK cells
isolated ex vivo from HIV-infected individuals.
Materials and methods
NK cell puriﬁcation and culture
Peripheral blood was obtained from volunteers using a protocol
approved by the Human Subjects Research Committee at UCLA.
Mononuclear cells were puriﬁed from whole blood over Ficoll-
Hypaque density gradients. NK cells were puriﬁed by negative
selection (Stemcell technologies) as described (Bernstein et al.,
2006), omitting CD4 antibody from the selection cocktail. NK cells
were conﬁrmed to be N99% pure following isolation (negative for the
lineage markers CD3, CD19, CD14, TCR α/β and γ/δ, and TCRVα24,
Vβ11) and were cultured with IL-2, IL-12 and PHA (NK media) to
induce CD4 expression for 7–10 days as previously described
(Bernstein et al., 2006).
Phenotypic analysis
Fluorescent-labeled antibody staining was performed following
puriﬁcation. Approximately 80% of the puriﬁed NK cells expressed
CD56 and these cells were negative for the lineagemarkers CD3, CD19,
and CD14, and were also negative for TCR α/β, γ/δ and TCRVα24,
Vβ11 as assessed by labeled antibody staining followed by ﬂow
cytometric analysis (Bernstein et al., 2002; Bernstein et al., 2006). Co-
receptor expression was assessed using the following ﬂuorochrome
labeled antibodies: CD56-FI (Ebiosciences), CXCR4-PE, CCR5-PE, CD3-
PerCP and CD4-APC (Coulter and Becton Dickinson). Intracellular
antibody staining was performed by surface labeling with the
ﬂuorochrome-labeled mAbs: CD56-PE, CD4-APC, and CD3-ECD,
followed by cell permeabilizationwith 0.2% Tween 20, and incubation
with KC57-FITC (p24 gag). Analysis was performed on a Becton
Dickinson FACSCalibur machine using CellQuest software. Cells weregated based on forward and side scatter, quadrant markers were set
based on isotype controls, and samples were compensated electro-
nically for overlap in ﬂuorescent emission.
Quantitation of CCR5 mRNA
Total RNA fromNK cells and PBMCswas extracted using the Qiagen
RNeasy kit and protocol. Reverse transcription and quantitative real-
time PCR were performed using Qiagen's SYBR green RT-PCR kit
starting with 30 ng total RNA per reaction. 500 nM of gene-speciﬁc
forward and reverse primers were utilized as follows: The reaction
conditions were 30 min at 50 °C (one cycle) and 15 min at 95 °C (one
cycle) for reverse transcription, and 15 s at 94 °C, 30 s at 60 °C and 30 s
at 72 °C (forty cycles) for PCR (Biswas et al., 2003; Chaitidis and Kuhn,
2005). Gene-speciﬁc products were continuously measured by means
of an icycler detection system (Biorad). Samples were normalized
based on expression of the housekeeping gene GAPDH.
HIV infection
NK cells were incubated with HIV-IIIB or HIV-Bal at an MOI of 0.1
for 3 h. For infections with primary viral isolates (BZ167, QZ4589,
96USHIPs) cells were added directly into virus stock in the presence of
10% FCS. Cells were then washed three times in wash media
containing PBS, 2% FCS, 12 mM HEPES (pH 7.2), 100 U/ml penicillin,
and 1 g/ml streptomycin. NK cells were then placed in culture at a
concentration of 105 cells/200 μl of NK media. In some assays cells
were cultured with anti-CCL-Igs (100 μg/ml polyclonal Igs speciﬁc to
CCL3, CCL4 and CCL5, R&D Systems), 10 μM AZT (Sigma), 1 μg/ml
AMD3100 (AIDS Reference and Repository Program), or 50 ng/ml
SDF-1α (R&D Systems) immediately prior and following virus
exposure.
Virus production
Virus production was assessed by p24 antigen quantitation in cell
culture supernatants as described, infections were performed in
duplicate (Wang et al., 2008). Infectious virus release was determined
by limiting dilution assay performed on days 7 and 10 post-infection
(Chun et al., 1997). Cell culture supernatant from HIV-infected NK
cells, cultured in the presence or absence of AZT, was added to PHA
stimulated blasts in serial 4 fold dilutions. HIV-infection of blasts was
determined by p24 release into supernatant and calculation of
infectious HIV particles/ml was performed using standard methods.
NK cell cytotoxicity assay
K562, Daudi, and Ramos cells were obtained from the American
Tissue Culture Collection (Manassas, VA) and 2F7 cells were
obtained from Dr. Benjamin Bonavida. Cell lines were maintained
in RPMI 1640 supplemented with 10% heat-inactivated fetal calf
serum (FCS), 1 mM L-glutamine, 100 U/ml penicillin and 50 μg/ml
streptomycin. Prior to use in cytotoxicity assays approximately
2×106 target cells were incubated with 100 μCi 51Cr (Perkin Elmer,
Boston, MA) for 1.5 h at 37 °C, washed, and incubated again for
30 min in RPMI/10% FCS for labeling. NK cells (effectors) were
ﬁcolled to remove dead cells; a comparison of equal numbers of
viable untouched and ﬁcolled cells indicated that no effector cells
were lost during ﬁcol puriﬁcation.
A starting NK cell to target ratio of 10:1 (50,000 cells/well) was
used, with two-fold serial dilutions and three replicates per
concentration. Target and effector cells were placed in a 96-well
round bottom plate for 4 h at 37 °C. Target cells were also incubated
with 0.5% Triton X to measure total release and with culture medium
alone to measure spontaneous release, with 6 replicates each.
Supernatants were harvested, placed into a scintillant-coated Luma
66 H.B. Bernstein et al. / Virology 387 (2009) 59–66Plate 96 (Perkin Elmer), and read in aWallac Microbeta Trilux counter
(Perkin Elmer) when dry. The percent lysis of each type of target cell
was calculated by subtracting the spontaneous release from the
experimental counts and dividing it by the total release minus the
spontaneous release (means of all replicates were used). Data was
analyzed using a two-sided Wilcoxon Rank Sum test with appropriate
corrections for multiple analyses.
NK cell migration assay
NK cells were placed in the upper well of a Costar 24-well
transwell plate with 8 μm pores. Six hundred microliters of either
RPMI/10% FCS, RPMI/10% FCS with 20 ng/ml SDF1-α (R&D Systems),
or RPMI/10% FCS with 200 ng/ml IL-16 (R&D Systems) were placed
in the bottom well in replicates of three. After 4 h of incubation at
37 °C, the cells in each lower well were counted twice and migration
in response to “plain media” (RPMI/10%FCS) was set as 100%.
Migration in response to chemoattractants was calculated based on
the percent above spontaneous migration as described (Bernstein et
al., 2006). NK cell migration was analyzed using the Wilcoxon Rank
Sum test.
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